1. ScholarBank@NUS

BHATTACHARYA BHASKAR UMAS

rp03295

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
BHATTACHARYA BHASKAR UMAS
Variants
Bhattacharya, B.
 
Main Affiliation
 
Faculty
 
Email
csibbu@nus.edu.sg
 

Publications

Results 1-6 of 6 (Search time: 0.009 seconds).

Issue DateTitleAuthor(s)
12016Acquired resistance to combination treatment through loss of synergy with MEK and PI3K inhibitors in colorectal cancerBhattacharya B. ; Low S.H.H. ; Chong M.L. ; Chia D.; Koh K.X.; Sapari N.S. ; Kaye S.; Hung H.; Benoukraf T. ; Soong R. 
22017Acquired resistance to PI3K/mTOR inhibition is associated with mitochondrial DNA mutation and glycolysisKoh K.X.; Tan G.H.; Low S.H.H. ; Omar M.F.M. ; Han M.J.; Iacopetta B.; Soo R. ; Beloueche-Babari M.; Bhattacharya B. ; Soong R. 
3Apr-2012Clinical and therapeutic relevance of PIM1 kinase in gastric cancerYan, B.; Yau, E.X. ; Samanta, S.; Ong, C.W. ; Yong, K.J.; Ng, L.K.; Bhattacharya, B. ; Lim, K.H.; Soong, R. ; Yeoh, K.G.; Deng, N. ; Tan, P. ; Lam, Y. ; Salto-Tellez, M. 
42011Low cytosine triphosphate synthase 2 expression renders resistance to 5-fluorouracil in colorectal cancerTan, W.L.; Bhattacharya, B. ; Loh, M. ; Balasubramanian, I. ; Akram, M.; Dong, D. ; Wong, L. ; Thakkar, B. ; Salto-Tellez, M. ; Soo, R.A. ; Fichtner, I.; Iacopetta, B.; Soong, R. 
51-Jan-2012Pharmacologic synergy between dual phosphoinositide-3-kinase and mammalian target of rapamycin inhibition and 5-Fluorouracil in PIK3CA mutant gastric cancer cellsBhattacharya, B. ; Akram, M.; Balasubramanian, I. ; Tam, K.K.Y.; Koh, K.X.; Yee, M.Q.; Soong, R. 
61-Jan-2012Pharmacologic synergy between dual phosphoinositide-3-kinase and mammalian target of rapamycin inhibition and 5-fluorouracil in PIK3CA mutant gastric cancer cells.Bhattacharya, B. ; Akram, M.; Balasubramanian, I.; Tam, K.K.; Koh, K.X.; Yee, M.Q.; Soong, R.